Global Erectile Dysfunction Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Corrosion Under Insulation (CUI) Monitoring market size is predicted to grow from US$ 214 million in 2025 to US$ 260 million in 2031; it is expected to grow at a CAGR of 3.3% from 2025 to 2031.
Corrosion under insulation (CUI) poses a significant operational loss, safety hazard and economic cost. Corrosion under insulation (CUI) is invisible to the surface of the insulation. Because of this, it is very difficult for conventional techniques to detect and monitor corrosion under insulation. The presence of moisture in and under insulation is the root cause of corrosion under insulation (CUI). Corrosion under insulation is a severe form of localized external corrosion that occurs in carbon and low alloy steel equipment that has been insulated. This form of corrosion occurs when water is absorbed by or collected in the insulation. As a result he equipment begins to corrode as it is exposed to water and oxygen. Depending on the structure and the location of the insulation, CUI can attack the jacketing, insulation hardware or underlying piping equipment. Additionally, when insulation becomes wet or absorbs moisture, its thermal insulating properties are drastically reduced. Because water conducts heat more efficiently than air, an aggressive corrosion cell is created where the trapped heat accelerates the rate of corrosion.
Global key players of Corrosion Under Insulation (CUI) Monitoring include Mistras, QSA Global, Inc. , Previan (Eddyfi), Kaefer Group, Alabama Specialty Products (Metal Samples) and Applied Technical Services, LLC, etc. The top six manufacturers hold a share over 65%.
LPI (LP Information)' newest research report, the “Corrosion Under Insulation (CUI) Monitoring Industry Forecast” looks at past sales and reviews total world Corrosion Under Insulation (CUI) Monitoring sales in 2024, providing a comprehensive analysis by region and market sector of projected Corrosion Under Insulation (CUI) Monitoring sales for 2025 through 2031. With Corrosion Under Insulation (CUI) Monitoring sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Corrosion Under Insulation (CUI) Monitoring industry.
This Insight Report provides a comprehensive analysis of the global Corrosion Under Insulation (CUI) Monitoring landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Corrosion Under Insulation (CUI) Monitoring portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Corrosion Under Insulation (CUI) Monitoring market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Corrosion Under Insulation (CUI) Monitoring and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Corrosion Under Insulation (CUI) Monitoring.
This report presents a comprehensive overview, market shares, and growth opportunities of Corrosion Under Insulation (CUI) Monitoring market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global Corrosion Under Insulation (CUI) Monitoring market size is predicted to grow from US$ 214 million in 2025 to US$ 260 million in 2031; it is expected to grow at a CAGR of 3.3% from 2025 to 2031.
Corrosion under insulation (CUI) poses a significant operational loss, safety hazard and economic cost. Corrosion under insulation (CUI) is invisible to the surface of the insulation. Because of this, it is very difficult for conventional techniques to detect and monitor corrosion under insulation. The presence of moisture in and under insulation is the root cause of corrosion under insulation (CUI). Corrosion under insulation is a severe form of localized external corrosion that occurs in carbon and low alloy steel equipment that has been insulated. This form of corrosion occurs when water is absorbed by or collected in the insulation. As a result he equipment begins to corrode as it is exposed to water and oxygen. Depending on the structure and the location of the insulation, CUI can attack the jacketing, insulation hardware or underlying piping equipment. Additionally, when insulation becomes wet or absorbs moisture, its thermal insulating properties are drastically reduced. Because water conducts heat more efficiently than air, an aggressive corrosion cell is created where the trapped heat accelerates the rate of corrosion.
Global key players of Corrosion Under Insulation (CUI) Monitoring include Mistras, QSA Global, Inc. , Previan (Eddyfi), Kaefer Group, Alabama Specialty Products (Metal Samples) and Applied Technical Services, LLC, etc. The top six manufacturers hold a share over 65%.
LPI (LP Information)' newest research report, the “Corrosion Under Insulation (CUI) Monitoring Industry Forecast” looks at past sales and reviews total world Corrosion Under Insulation (CUI) Monitoring sales in 2024, providing a comprehensive analysis by region and market sector of projected Corrosion Under Insulation (CUI) Monitoring sales for 2025 through 2031. With Corrosion Under Insulation (CUI) Monitoring sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Corrosion Under Insulation (CUI) Monitoring industry.
This Insight Report provides a comprehensive analysis of the global Corrosion Under Insulation (CUI) Monitoring landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Corrosion Under Insulation (CUI) Monitoring portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Corrosion Under Insulation (CUI) Monitoring market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Corrosion Under Insulation (CUI) Monitoring and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Corrosion Under Insulation (CUI) Monitoring.
This report presents a comprehensive overview, market shares, and growth opportunities of Corrosion Under Insulation (CUI) Monitoring market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Hardware
- Software
- Services
- Oil & Gas
- Marine
- Chemical & Petrochemical
- Energy & Power
- Food Processing Industries
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Mistras
- QSA Global, Inc.
- Previan (Eddyfi)
- Kaefer Group
- Alabama Specialty Products (Metal Samples)
- Applied Technical Services, LLC
- Testex Inc
- Rohrback Cosasco Systems (RCS)
- 3-Sci Limited
- CorrosionRADAR
- iSensPro
- ESR Technology
- Maxwell NDT
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Erectile Dysfunction Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Erectile Dysfunction by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Erectile Dysfunction by Country/Region, 2020, 2024 & 2031
2.2 Erectile Dysfunction Segment by Type
2.2.1 Sildenafil
2.2.2 Tadalafil
2.2.3 Others
2.3 Erectile Dysfunction Sales by Type
2.3.1 Global Erectile Dysfunction Sales Market Share by Type (2020-2025)
2.3.2 Global Erectile Dysfunction Revenue and Market Share by Type (2020-2025)
2.3.3 Global Erectile Dysfunction Sale Price by Type (2020-2025)
2.4 Erectile Dysfunction Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Private Clinics
2.4.3 Retail Pharmacies
2.4.4 E-Commerce (B2B)
2.4.5 E-Commerce (B2C)
2.5 Erectile Dysfunction Sales by Application
2.5.1 Global Erectile Dysfunction Sale Market Share by Application (2020-2025)
2.5.2 Global Erectile Dysfunction Revenue and Market Share by Application (2020-2025)
2.5.3 Global Erectile Dysfunction Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Erectile Dysfunction Breakdown Data by Company
3.1.1 Global Erectile Dysfunction Annual Sales by Company (2020-2025)
3.1.2 Global Erectile Dysfunction Sales Market Share by Company (2020-2025)
3.2 Global Erectile Dysfunction Annual Revenue by Company (2020-2025)
3.2.1 Global Erectile Dysfunction Revenue by Company (2020-2025)
3.2.2 Global Erectile Dysfunction Revenue Market Share by Company (2020-2025)
3.3 Global Erectile Dysfunction Sale Price by Company
3.4 Key Manufacturers Erectile Dysfunction Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Erectile Dysfunction Product Location Distribution
3.4.2 Players Erectile Dysfunction Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ERECTILE DYSFUNCTION BY GEOGRAPHIC REGION
4.1 World Historic Erectile Dysfunction Market Size by Geographic Region (2020-2025)
4.1.1 Global Erectile Dysfunction Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Erectile Dysfunction Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Erectile Dysfunction Market Size by Country/Region (2020-2025)
4.2.1 Global Erectile Dysfunction Annual Sales by Country/Region (2020-2025)
4.2.2 Global Erectile Dysfunction Annual Revenue by Country/Region (2020-2025)
4.3 Americas Erectile Dysfunction Sales Growth
4.4 APAC Erectile Dysfunction Sales Growth
4.5 Europe Erectile Dysfunction Sales Growth
4.6 Middle East & Africa Erectile Dysfunction Sales Growth
5 AMERICAS
5.1 Americas Erectile Dysfunction Sales by Country
5.1.1 Americas Erectile Dysfunction Sales by Country (2020-2025)
5.1.2 Americas Erectile Dysfunction Revenue by Country (2020-2025)
5.2 Americas Erectile Dysfunction Sales by Type (2020-2025)
5.3 Americas Erectile Dysfunction Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Erectile Dysfunction Sales by Region
6.1.1 APAC Erectile Dysfunction Sales by Region (2020-2025)
6.1.2 APAC Erectile Dysfunction Revenue by Region (2020-2025)
6.2 APAC Erectile Dysfunction Sales by Type (2020-2025)
6.3 APAC Erectile Dysfunction Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Erectile Dysfunction by Country
7.1.1 Europe Erectile Dysfunction Sales by Country (2020-2025)
7.1.2 Europe Erectile Dysfunction Revenue by Country (2020-2025)
7.2 Europe Erectile Dysfunction Sales by Type (2020-2025)
7.3 Europe Erectile Dysfunction Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Erectile Dysfunction by Country
8.1.1 Middle East & Africa Erectile Dysfunction Sales by Country (2020-2025)
8.1.2 Middle East & Africa Erectile Dysfunction Revenue by Country (2020-2025)
8.2 Middle East & Africa Erectile Dysfunction Sales by Type (2020-2025)
8.3 Middle East & Africa Erectile Dysfunction Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Erectile Dysfunction
10.3 Manufacturing Process Analysis of Erectile Dysfunction
10.4 Industry Chain Structure of Erectile Dysfunction
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Erectile Dysfunction Distributors
11.3 Erectile Dysfunction Customer
12 WORLD FORECAST REVIEW FOR ERECTILE DYSFUNCTION BY GEOGRAPHIC REGION
12.1 Global Erectile Dysfunction Market Size Forecast by Region
12.1.1 Global Erectile Dysfunction Forecast by Region (2026-2031)
12.1.2 Global Erectile Dysfunction Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Erectile Dysfunction Forecast by Type (2026-2031)
12.7 Global Erectile Dysfunction Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Eli Lilly
13.1.1 Eli Lilly Company Information
13.1.2 Eli Lilly Erectile Dysfunction Product Portfolios and Specifications
13.1.3 Eli Lilly Erectile Dysfunction Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Eli Lilly Main Business Overview
13.1.5 Eli Lilly Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Erectile Dysfunction Product Portfolios and Specifications
13.2.3 Pfizer Erectile Dysfunction Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Bayer
13.3.1 Bayer Company Information
13.3.2 Bayer Erectile Dysfunction Product Portfolios and Specifications
13.3.3 Bayer Erectile Dysfunction Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Bayer Main Business Overview
13.3.5 Bayer Latest Developments
13.4 BaiYunShan General Factory
13.4.1 BaiYunShan General Factory Company Information
13.4.2 BaiYunShan General Factory Erectile Dysfunction Product Portfolios and Specifications
13.4.3 BaiYunShan General Factory Erectile Dysfunction Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 BaiYunShan General Factory Main Business Overview
13.4.5 BaiYunShan General Factory Latest Developments
13.5 S.K. Chemicals
13.5.1 S.K. Chemicals Company Information
13.5.2 S.K. Chemicals Erectile Dysfunction Product Portfolios and Specifications
13.5.3 S.K. Chemicals Erectile Dysfunction Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 S.K. Chemicals Main Business Overview
13.5.5 S.K. Chemicals Latest Developments
13.6 Teva Pharma
13.6.1 Teva Pharma Company Information
13.6.2 Teva Pharma Erectile Dysfunction Product Portfolios and Specifications
13.6.3 Teva Pharma Erectile Dysfunction Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Teva Pharma Main Business Overview
13.6.5 Teva Pharma Latest Developments
13.7 Dong-A ST
13.7.1 Dong-A ST Company Information
13.7.2 Dong-A ST Erectile Dysfunction Product Portfolios and Specifications
13.7.3 Dong-A ST Erectile Dysfunction Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Dong-A ST Main Business Overview
13.7.5 Dong-A ST Latest Developments
13.8 Petros Pharmaceuticals
13.8.1 Petros Pharmaceuticals Company Information
13.8.2 Petros Pharmaceuticals Erectile Dysfunction Product Portfolios and Specifications
13.8.3 Petros Pharmaceuticals Erectile Dysfunction Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Petros Pharmaceuticals Main Business Overview
13.8.5 Petros Pharmaceuticals Latest Developments
13.9 Seoul Pharma
13.9.1 Seoul Pharma Company Information
13.9.2 Seoul Pharma Erectile Dysfunction Product Portfolios and Specifications
13.9.3 Seoul Pharma Erectile Dysfunction Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Seoul Pharma Main Business Overview
13.9.5 Seoul Pharma Latest Developments
13.10 Yabang Pharmacy
13.10.1 Yabang Pharmacy Company Information
13.10.2 Yabang Pharmacy Erectile Dysfunction Product Portfolios and Specifications
13.10.3 Yabang Pharmacy Erectile Dysfunction Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Yabang Pharmacy Main Business Overview
13.10.5 Yabang Pharmacy Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Erectile Dysfunction Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Erectile Dysfunction by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Erectile Dysfunction by Country/Region, 2020, 2024 & 2031
2.2 Erectile Dysfunction Segment by Type
2.2.1 Sildenafil
2.2.2 Tadalafil
2.2.3 Others
2.3 Erectile Dysfunction Sales by Type
2.3.1 Global Erectile Dysfunction Sales Market Share by Type (2020-2025)
2.3.2 Global Erectile Dysfunction Revenue and Market Share by Type (2020-2025)
2.3.3 Global Erectile Dysfunction Sale Price by Type (2020-2025)
2.4 Erectile Dysfunction Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Private Clinics
2.4.3 Retail Pharmacies
2.4.4 E-Commerce (B2B)
2.4.5 E-Commerce (B2C)
2.5 Erectile Dysfunction Sales by Application
2.5.1 Global Erectile Dysfunction Sale Market Share by Application (2020-2025)
2.5.2 Global Erectile Dysfunction Revenue and Market Share by Application (2020-2025)
2.5.3 Global Erectile Dysfunction Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Erectile Dysfunction Breakdown Data by Company
3.1.1 Global Erectile Dysfunction Annual Sales by Company (2020-2025)
3.1.2 Global Erectile Dysfunction Sales Market Share by Company (2020-2025)
3.2 Global Erectile Dysfunction Annual Revenue by Company (2020-2025)
3.2.1 Global Erectile Dysfunction Revenue by Company (2020-2025)
3.2.2 Global Erectile Dysfunction Revenue Market Share by Company (2020-2025)
3.3 Global Erectile Dysfunction Sale Price by Company
3.4 Key Manufacturers Erectile Dysfunction Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Erectile Dysfunction Product Location Distribution
3.4.2 Players Erectile Dysfunction Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ERECTILE DYSFUNCTION BY GEOGRAPHIC REGION
4.1 World Historic Erectile Dysfunction Market Size by Geographic Region (2020-2025)
4.1.1 Global Erectile Dysfunction Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Erectile Dysfunction Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Erectile Dysfunction Market Size by Country/Region (2020-2025)
4.2.1 Global Erectile Dysfunction Annual Sales by Country/Region (2020-2025)
4.2.2 Global Erectile Dysfunction Annual Revenue by Country/Region (2020-2025)
4.3 Americas Erectile Dysfunction Sales Growth
4.4 APAC Erectile Dysfunction Sales Growth
4.5 Europe Erectile Dysfunction Sales Growth
4.6 Middle East & Africa Erectile Dysfunction Sales Growth
5 AMERICAS
5.1 Americas Erectile Dysfunction Sales by Country
5.1.1 Americas Erectile Dysfunction Sales by Country (2020-2025)
5.1.2 Americas Erectile Dysfunction Revenue by Country (2020-2025)
5.2 Americas Erectile Dysfunction Sales by Type (2020-2025)
5.3 Americas Erectile Dysfunction Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Erectile Dysfunction Sales by Region
6.1.1 APAC Erectile Dysfunction Sales by Region (2020-2025)
6.1.2 APAC Erectile Dysfunction Revenue by Region (2020-2025)
6.2 APAC Erectile Dysfunction Sales by Type (2020-2025)
6.3 APAC Erectile Dysfunction Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Erectile Dysfunction by Country
7.1.1 Europe Erectile Dysfunction Sales by Country (2020-2025)
7.1.2 Europe Erectile Dysfunction Revenue by Country (2020-2025)
7.2 Europe Erectile Dysfunction Sales by Type (2020-2025)
7.3 Europe Erectile Dysfunction Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Erectile Dysfunction by Country
8.1.1 Middle East & Africa Erectile Dysfunction Sales by Country (2020-2025)
8.1.2 Middle East & Africa Erectile Dysfunction Revenue by Country (2020-2025)
8.2 Middle East & Africa Erectile Dysfunction Sales by Type (2020-2025)
8.3 Middle East & Africa Erectile Dysfunction Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Erectile Dysfunction
10.3 Manufacturing Process Analysis of Erectile Dysfunction
10.4 Industry Chain Structure of Erectile Dysfunction
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Erectile Dysfunction Distributors
11.3 Erectile Dysfunction Customer
12 WORLD FORECAST REVIEW FOR ERECTILE DYSFUNCTION BY GEOGRAPHIC REGION
12.1 Global Erectile Dysfunction Market Size Forecast by Region
12.1.1 Global Erectile Dysfunction Forecast by Region (2026-2031)
12.1.2 Global Erectile Dysfunction Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Erectile Dysfunction Forecast by Type (2026-2031)
12.7 Global Erectile Dysfunction Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Eli Lilly
13.1.1 Eli Lilly Company Information
13.1.2 Eli Lilly Erectile Dysfunction Product Portfolios and Specifications
13.1.3 Eli Lilly Erectile Dysfunction Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Eli Lilly Main Business Overview
13.1.5 Eli Lilly Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Erectile Dysfunction Product Portfolios and Specifications
13.2.3 Pfizer Erectile Dysfunction Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Bayer
13.3.1 Bayer Company Information
13.3.2 Bayer Erectile Dysfunction Product Portfolios and Specifications
13.3.3 Bayer Erectile Dysfunction Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Bayer Main Business Overview
13.3.5 Bayer Latest Developments
13.4 BaiYunShan General Factory
13.4.1 BaiYunShan General Factory Company Information
13.4.2 BaiYunShan General Factory Erectile Dysfunction Product Portfolios and Specifications
13.4.3 BaiYunShan General Factory Erectile Dysfunction Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 BaiYunShan General Factory Main Business Overview
13.4.5 BaiYunShan General Factory Latest Developments
13.5 S.K. Chemicals
13.5.1 S.K. Chemicals Company Information
13.5.2 S.K. Chemicals Erectile Dysfunction Product Portfolios and Specifications
13.5.3 S.K. Chemicals Erectile Dysfunction Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 S.K. Chemicals Main Business Overview
13.5.5 S.K. Chemicals Latest Developments
13.6 Teva Pharma
13.6.1 Teva Pharma Company Information
13.6.2 Teva Pharma Erectile Dysfunction Product Portfolios and Specifications
13.6.3 Teva Pharma Erectile Dysfunction Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Teva Pharma Main Business Overview
13.6.5 Teva Pharma Latest Developments
13.7 Dong-A ST
13.7.1 Dong-A ST Company Information
13.7.2 Dong-A ST Erectile Dysfunction Product Portfolios and Specifications
13.7.3 Dong-A ST Erectile Dysfunction Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Dong-A ST Main Business Overview
13.7.5 Dong-A ST Latest Developments
13.8 Petros Pharmaceuticals
13.8.1 Petros Pharmaceuticals Company Information
13.8.2 Petros Pharmaceuticals Erectile Dysfunction Product Portfolios and Specifications
13.8.3 Petros Pharmaceuticals Erectile Dysfunction Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Petros Pharmaceuticals Main Business Overview
13.8.5 Petros Pharmaceuticals Latest Developments
13.9 Seoul Pharma
13.9.1 Seoul Pharma Company Information
13.9.2 Seoul Pharma Erectile Dysfunction Product Portfolios and Specifications
13.9.3 Seoul Pharma Erectile Dysfunction Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Seoul Pharma Main Business Overview
13.9.5 Seoul Pharma Latest Developments
13.10 Yabang Pharmacy
13.10.1 Yabang Pharmacy Company Information
13.10.2 Yabang Pharmacy Erectile Dysfunction Product Portfolios and Specifications
13.10.3 Yabang Pharmacy Erectile Dysfunction Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Yabang Pharmacy Main Business Overview
13.10.5 Yabang Pharmacy Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Erectile Dysfunction Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Erectile Dysfunction Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Sildenafil
Table 4. Major Players ofTadalafil
Table 5. Major Players of Others
Table 6. Global Erectile Dysfunction Sales byType (2020-2025) & (Million Pill)
Table 7. Global Erectile Dysfunction Sales Market Share byType (2020-2025)
Table 8. Global Erectile Dysfunction Revenue byType (2020-2025) & ($ million)
Table 9. Global Erectile Dysfunction Revenue Market Share byType (2020-2025)
Table 10. Global Erectile Dysfunction Sale Price byType (2020-2025) & (USD/Pill)
Table 11. Global Erectile Dysfunction Sale by Application (2020-2025) & (Million Pill)
Table 12. Global Erectile Dysfunction Sale Market Share by Application (2020-2025)
Table 13. Global Erectile Dysfunction Revenue by Application (2020-2025) & ($ million)
Table 14. Global Erectile Dysfunction Revenue Market Share by Application (2020-2025)
Table 15. Global Erectile Dysfunction Sale Price by Application (2020-2025) & (USD/Pill)
Table 16. Global Erectile Dysfunction Sales by Company (2020-2025) & (Million Pill)
Table 17. Global Erectile Dysfunction Sales Market Share by Company (2020-2025)
Table 18. Global Erectile Dysfunction Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Erectile Dysfunction Revenue Market Share by Company (2020-2025)
Table 20. Global Erectile Dysfunction Sale Price by Company (2020-2025) & (USD/Pill)
Table 21. Key Manufacturers Erectile Dysfunction Producing Area Distribution and Sales Area
Table 22. Players Erectile Dysfunction Products Offered
Table 23. Erectile Dysfunction Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Erectile Dysfunction Sales by Geographic Region (2020-2025) & (Million Pill)
Table 27. Global Erectile Dysfunction Sales Market Share Geographic Region (2020-2025)
Table 28. Global Erectile Dysfunction Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Erectile Dysfunction Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Erectile Dysfunction Sales by Country/Region (2020-2025) & (Million Pill)
Table 31. Global Erectile Dysfunction Sales Market Share by Country/Region (2020-2025)
Table 32. Global Erectile Dysfunction Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Erectile Dysfunction Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Erectile Dysfunction Sales by Country (2020-2025) & (Million Pill)
Table 35. Americas Erectile Dysfunction Sales Market Share by Country (2020-2025)
Table 36. Americas Erectile Dysfunction Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Erectile Dysfunction Sales byType (2020-2025) & (Million Pill)
Table 38. Americas Erectile Dysfunction Sales by Application (2020-2025) & (Million Pill)
Table 39. APAC Erectile Dysfunction Sales by Region (2020-2025) & (Million Pill)
Table 40. APAC Erectile Dysfunction Sales Market Share by Region (2020-2025)
Table 41. APAC Erectile Dysfunction Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Erectile Dysfunction Sales byType (2020-2025) & (Million Pill)
Table 43. APAC Erectile Dysfunction Sales by Application (2020-2025) & (Million Pill)
Table 44. Europe Erectile Dysfunction Sales by Country (2020-2025) & (Million Pill)
Table 45. Europe Erectile Dysfunction Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Erectile Dysfunction Sales byType (2020-2025) & (Million Pill)
Table 47. Europe Erectile Dysfunction Sales by Application (2020-2025) & (Million Pill)
Table 48. Middle East & Africa Erectile Dysfunction Sales by Country (2020-2025) & (Million Pill)
Table 49. Middle East & Africa Erectile Dysfunction Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Erectile Dysfunction Sales byType (2020-2025) & (Million Pill)
Table 51. Middle East & Africa Erectile Dysfunction Sales by Application (2020-2025) & (Million Pill)
Table 52. Key Market Drivers & Growth Opportunities of Erectile Dysfunction
Table 53. Key Market Challenges & Risks of Erectile Dysfunction
Table 54. Key IndustryTrends of Erectile Dysfunction
Table 55. Erectile Dysfunction Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Erectile Dysfunction Distributors List
Table 58. Erectile Dysfunction Customer List
Table 59. Global Erectile Dysfunction SalesForecast by Region (2026-2031) & (Million Pill)
Table 60. Global Erectile Dysfunction RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Erectile Dysfunction SalesForecast by Country (2026-2031) & (Million Pill)
Table 62. Americas Erectile Dysfunction Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Erectile Dysfunction SalesForecast by Region (2026-2031) & (Million Pill)
Table 64. APAC Erectile Dysfunction Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Erectile Dysfunction SalesForecast by Country (2026-2031) & (Million Pill)
Table 66. Europe Erectile Dysfunction RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Erectile Dysfunction SalesForecast by Country (2026-2031) & (Million Pill)
Table 68. Middle East & Africa Erectile Dysfunction RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Erectile Dysfunction SalesForecast byType (2026-2031) & (Million Pill)
Table 70. Global Erectile Dysfunction RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Erectile Dysfunction SalesForecast by Application (2026-2031) & (Million Pill)
Table 72. Global Erectile Dysfunction RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Eli Lilly Basic Information, Erectile Dysfunction Manufacturing Base, Sales Area and Its Competitors
Table 74. Eli Lilly Erectile Dysfunction Product Portfolios and Specifications
Table 75. Eli Lilly Erectile Dysfunction Sales (Million Pill), Revenue ($ Million), Price (USD/Pill) and Gross Margin (2020-2025)
Table 76. Eli Lilly Main Business
Table 77. Eli Lilly Latest Developments
Table 78. Pfizer Basic Information, Erectile Dysfunction Manufacturing Base, Sales Area and Its Competitors
Table 79. Pfizer Erectile Dysfunction Product Portfolios and Specifications
Table 80. Pfizer Erectile Dysfunction Sales (Million Pill), Revenue ($ Million), Price (USD/Pill) and Gross Margin (2020-2025)
Table 81. Pfizer Main Business
Table 82. Pfizer Latest Developments
Table 83. Bayer Basic Information, Erectile Dysfunction Manufacturing Base, Sales Area and Its Competitors
Table 84. Bayer Erectile Dysfunction Product Portfolios and Specifications
Table 85. Bayer Erectile Dysfunction Sales (Million Pill), Revenue ($ Million), Price (USD/Pill) and Gross Margin (2020-2025)
Table 86. Bayer Main Business
Table 87. Bayer Latest Developments
Table 88. BaiYunShan GeneralFactory Basic Information, Erectile Dysfunction Manufacturing Base, Sales Area and Its Competitors
Table 89. BaiYunShan GeneralFactory Erectile Dysfunction Product Portfolios and Specifications
Table 90. BaiYunShan GeneralFactory Erectile Dysfunction Sales (Million Pill), Revenue ($ Million), Price (USD/Pill) and Gross Margin (2020-2025)
Table 91. BaiYunShan GeneralFactory Main Business
Table 92. BaiYunShan GeneralFactory Latest Developments
Table 93. S.K. Chemicals Basic Information, Erectile Dysfunction Manufacturing Base, Sales Area and Its Competitors
Table 94. S.K. Chemicals Erectile Dysfunction Product Portfolios and Specifications
Table 95. S.K. Chemicals Erectile Dysfunction Sales (Million Pill), Revenue ($ Million), Price (USD/Pill) and Gross Margin (2020-2025)
Table 96. S.K. Chemicals Main Business
Table 97. S.K. Chemicals Latest Developments
Table 98.Teva Pharma Basic Information, Erectile Dysfunction Manufacturing Base, Sales Area and Its Competitors
Table 99.Teva Pharma Erectile Dysfunction Product Portfolios and Specifications
Table 100.Teva Pharma Erectile Dysfunction Sales (Million Pill), Revenue ($ Million), Price (USD/Pill) and Gross Margin (2020-2025)
Table 101.Teva Pharma Main Business
Table 102.Teva Pharma Latest Developments
Table 103. Dong-A ST Basic Information, Erectile Dysfunction Manufacturing Base, Sales Area and Its Competitors
Table 104. Dong-A ST Erectile Dysfunction Product Portfolios and Specifications
Table 105. Dong-A ST Erectile Dysfunction Sales (Million Pill), Revenue ($ Million), Price (USD/Pill) and Gross Margin (2020-2025)
Table 106. Dong-A ST Main Business
Table 107. Dong-A ST Latest Developments
Table 108. Petros Pharmaceuticals Basic Information, Erectile Dysfunction Manufacturing Base, Sales Area and Its Competitors
Table 109. Petros Pharmaceuticals Erectile Dysfunction Product Portfolios and Specifications
Table 110. Petros Pharmaceuticals Erectile Dysfunction Sales (Million Pill), Revenue ($ Million), Price (USD/Pill) and Gross Margin (2020-2025)
Table 111. Petros Pharmaceuticals Main Business
Table 112. Petros Pharmaceuticals Latest Developments
Table 113. Seoul Pharma Basic Information, Erectile Dysfunction Manufacturing Base, Sales Area and Its Competitors
Table 114. Seoul Pharma Erectile Dysfunction Product Portfolios and Specifications
Table 115. Seoul Pharma Erectile Dysfunction Sales (Million Pill), Revenue ($ Million), Price (USD/Pill) and Gross Margin (2020-2025)
Table 116. Seoul Pharma Main Business
Table 117. Seoul Pharma Latest Developments
Table 118. Yabang Pharmacy Basic Information, Erectile Dysfunction Manufacturing Base, Sales Area and Its Competitors
Table 119. Yabang Pharmacy Erectile Dysfunction Product Portfolios and Specifications
Table 120. Yabang Pharmacy Erectile Dysfunction Sales (Million Pill), Revenue ($ Million), Price (USD/Pill) and Gross Margin (2020-2025)
Table 121. Yabang Pharmacy Main Business
Table 122. Yabang Pharmacy Latest Developments
Table 1. Erectile Dysfunction Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Erectile Dysfunction Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Sildenafil
Table 4. Major Players ofTadalafil
Table 5. Major Players of Others
Table 6. Global Erectile Dysfunction Sales byType (2020-2025) & (Million Pill)
Table 7. Global Erectile Dysfunction Sales Market Share byType (2020-2025)
Table 8. Global Erectile Dysfunction Revenue byType (2020-2025) & ($ million)
Table 9. Global Erectile Dysfunction Revenue Market Share byType (2020-2025)
Table 10. Global Erectile Dysfunction Sale Price byType (2020-2025) & (USD/Pill)
Table 11. Global Erectile Dysfunction Sale by Application (2020-2025) & (Million Pill)
Table 12. Global Erectile Dysfunction Sale Market Share by Application (2020-2025)
Table 13. Global Erectile Dysfunction Revenue by Application (2020-2025) & ($ million)
Table 14. Global Erectile Dysfunction Revenue Market Share by Application (2020-2025)
Table 15. Global Erectile Dysfunction Sale Price by Application (2020-2025) & (USD/Pill)
Table 16. Global Erectile Dysfunction Sales by Company (2020-2025) & (Million Pill)
Table 17. Global Erectile Dysfunction Sales Market Share by Company (2020-2025)
Table 18. Global Erectile Dysfunction Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Erectile Dysfunction Revenue Market Share by Company (2020-2025)
Table 20. Global Erectile Dysfunction Sale Price by Company (2020-2025) & (USD/Pill)
Table 21. Key Manufacturers Erectile Dysfunction Producing Area Distribution and Sales Area
Table 22. Players Erectile Dysfunction Products Offered
Table 23. Erectile Dysfunction Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Erectile Dysfunction Sales by Geographic Region (2020-2025) & (Million Pill)
Table 27. Global Erectile Dysfunction Sales Market Share Geographic Region (2020-2025)
Table 28. Global Erectile Dysfunction Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Erectile Dysfunction Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Erectile Dysfunction Sales by Country/Region (2020-2025) & (Million Pill)
Table 31. Global Erectile Dysfunction Sales Market Share by Country/Region (2020-2025)
Table 32. Global Erectile Dysfunction Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Erectile Dysfunction Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Erectile Dysfunction Sales by Country (2020-2025) & (Million Pill)
Table 35. Americas Erectile Dysfunction Sales Market Share by Country (2020-2025)
Table 36. Americas Erectile Dysfunction Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Erectile Dysfunction Sales byType (2020-2025) & (Million Pill)
Table 38. Americas Erectile Dysfunction Sales by Application (2020-2025) & (Million Pill)
Table 39. APAC Erectile Dysfunction Sales by Region (2020-2025) & (Million Pill)
Table 40. APAC Erectile Dysfunction Sales Market Share by Region (2020-2025)
Table 41. APAC Erectile Dysfunction Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Erectile Dysfunction Sales byType (2020-2025) & (Million Pill)
Table 43. APAC Erectile Dysfunction Sales by Application (2020-2025) & (Million Pill)
Table 44. Europe Erectile Dysfunction Sales by Country (2020-2025) & (Million Pill)
Table 45. Europe Erectile Dysfunction Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Erectile Dysfunction Sales byType (2020-2025) & (Million Pill)
Table 47. Europe Erectile Dysfunction Sales by Application (2020-2025) & (Million Pill)
Table 48. Middle East & Africa Erectile Dysfunction Sales by Country (2020-2025) & (Million Pill)
Table 49. Middle East & Africa Erectile Dysfunction Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Erectile Dysfunction Sales byType (2020-2025) & (Million Pill)
Table 51. Middle East & Africa Erectile Dysfunction Sales by Application (2020-2025) & (Million Pill)
Table 52. Key Market Drivers & Growth Opportunities of Erectile Dysfunction
Table 53. Key Market Challenges & Risks of Erectile Dysfunction
Table 54. Key IndustryTrends of Erectile Dysfunction
Table 55. Erectile Dysfunction Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Erectile Dysfunction Distributors List
Table 58. Erectile Dysfunction Customer List
Table 59. Global Erectile Dysfunction SalesForecast by Region (2026-2031) & (Million Pill)
Table 60. Global Erectile Dysfunction RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Erectile Dysfunction SalesForecast by Country (2026-2031) & (Million Pill)
Table 62. Americas Erectile Dysfunction Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Erectile Dysfunction SalesForecast by Region (2026-2031) & (Million Pill)
Table 64. APAC Erectile Dysfunction Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Erectile Dysfunction SalesForecast by Country (2026-2031) & (Million Pill)
Table 66. Europe Erectile Dysfunction RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Erectile Dysfunction SalesForecast by Country (2026-2031) & (Million Pill)
Table 68. Middle East & Africa Erectile Dysfunction RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Erectile Dysfunction SalesForecast byType (2026-2031) & (Million Pill)
Table 70. Global Erectile Dysfunction RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Erectile Dysfunction SalesForecast by Application (2026-2031) & (Million Pill)
Table 72. Global Erectile Dysfunction RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Eli Lilly Basic Information, Erectile Dysfunction Manufacturing Base, Sales Area and Its Competitors
Table 74. Eli Lilly Erectile Dysfunction Product Portfolios and Specifications
Table 75. Eli Lilly Erectile Dysfunction Sales (Million Pill), Revenue ($ Million), Price (USD/Pill) and Gross Margin (2020-2025)
Table 76. Eli Lilly Main Business
Table 77. Eli Lilly Latest Developments
Table 78. Pfizer Basic Information, Erectile Dysfunction Manufacturing Base, Sales Area and Its Competitors
Table 79. Pfizer Erectile Dysfunction Product Portfolios and Specifications
Table 80. Pfizer Erectile Dysfunction Sales (Million Pill), Revenue ($ Million), Price (USD/Pill) and Gross Margin (2020-2025)
Table 81. Pfizer Main Business
Table 82. Pfizer Latest Developments
Table 83. Bayer Basic Information, Erectile Dysfunction Manufacturing Base, Sales Area and Its Competitors
Table 84. Bayer Erectile Dysfunction Product Portfolios and Specifications
Table 85. Bayer Erectile Dysfunction Sales (Million Pill), Revenue ($ Million), Price (USD/Pill) and Gross Margin (2020-2025)
Table 86. Bayer Main Business
Table 87. Bayer Latest Developments
Table 88. BaiYunShan GeneralFactory Basic Information, Erectile Dysfunction Manufacturing Base, Sales Area and Its Competitors
Table 89. BaiYunShan GeneralFactory Erectile Dysfunction Product Portfolios and Specifications
Table 90. BaiYunShan GeneralFactory Erectile Dysfunction Sales (Million Pill), Revenue ($ Million), Price (USD/Pill) and Gross Margin (2020-2025)
Table 91. BaiYunShan GeneralFactory Main Business
Table 92. BaiYunShan GeneralFactory Latest Developments
Table 93. S.K. Chemicals Basic Information, Erectile Dysfunction Manufacturing Base, Sales Area and Its Competitors
Table 94. S.K. Chemicals Erectile Dysfunction Product Portfolios and Specifications
Table 95. S.K. Chemicals Erectile Dysfunction Sales (Million Pill), Revenue ($ Million), Price (USD/Pill) and Gross Margin (2020-2025)
Table 96. S.K. Chemicals Main Business
Table 97. S.K. Chemicals Latest Developments
Table 98.Teva Pharma Basic Information, Erectile Dysfunction Manufacturing Base, Sales Area and Its Competitors
Table 99.Teva Pharma Erectile Dysfunction Product Portfolios and Specifications
Table 100.Teva Pharma Erectile Dysfunction Sales (Million Pill), Revenue ($ Million), Price (USD/Pill) and Gross Margin (2020-2025)
Table 101.Teva Pharma Main Business
Table 102.Teva Pharma Latest Developments
Table 103. Dong-A ST Basic Information, Erectile Dysfunction Manufacturing Base, Sales Area and Its Competitors
Table 104. Dong-A ST Erectile Dysfunction Product Portfolios and Specifications
Table 105. Dong-A ST Erectile Dysfunction Sales (Million Pill), Revenue ($ Million), Price (USD/Pill) and Gross Margin (2020-2025)
Table 106. Dong-A ST Main Business
Table 107. Dong-A ST Latest Developments
Table 108. Petros Pharmaceuticals Basic Information, Erectile Dysfunction Manufacturing Base, Sales Area and Its Competitors
Table 109. Petros Pharmaceuticals Erectile Dysfunction Product Portfolios and Specifications
Table 110. Petros Pharmaceuticals Erectile Dysfunction Sales (Million Pill), Revenue ($ Million), Price (USD/Pill) and Gross Margin (2020-2025)
Table 111. Petros Pharmaceuticals Main Business
Table 112. Petros Pharmaceuticals Latest Developments
Table 113. Seoul Pharma Basic Information, Erectile Dysfunction Manufacturing Base, Sales Area and Its Competitors
Table 114. Seoul Pharma Erectile Dysfunction Product Portfolios and Specifications
Table 115. Seoul Pharma Erectile Dysfunction Sales (Million Pill), Revenue ($ Million), Price (USD/Pill) and Gross Margin (2020-2025)
Table 116. Seoul Pharma Main Business
Table 117. Seoul Pharma Latest Developments
Table 118. Yabang Pharmacy Basic Information, Erectile Dysfunction Manufacturing Base, Sales Area and Its Competitors
Table 119. Yabang Pharmacy Erectile Dysfunction Product Portfolios and Specifications
Table 120. Yabang Pharmacy Erectile Dysfunction Sales (Million Pill), Revenue ($ Million), Price (USD/Pill) and Gross Margin (2020-2025)
Table 121. Yabang Pharmacy Main Business
Table 122. Yabang Pharmacy Latest Developments
LIST OF FIGURES
Figure 1. Picture of Erectile Dysfunction
Figure 2. Erectile Dysfunction Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Erectile Dysfunction Sales Growth Rate 2020-2031 (Million Pill)
Figure 7. Global Erectile Dysfunction Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Erectile Dysfunction Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Erectile Dysfunction Sales Market Share by Country/Region (2024)
Figure 10. Erectile Dysfunction Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Sildenafil
Figure 12. Product Picture ofTadalafil
Figure 13. Product Picture of Others
Figure 14. Global Erectile Dysfunction Sales Market Share byType in 2025
Figure 15. Global Erectile Dysfunction Revenue Market Share byType (2020-2025)
Figure 16. Erectile Dysfunction Consumed in Hospital Pharmacies
Figure 17. Global Erectile Dysfunction Market: Hospital Pharmacies (2020-2025) & (Million Pill)
Figure 18. Erectile Dysfunction Consumed in Private Clinics
Figure 19. Global Erectile Dysfunction Market: Private Clinics (2020-2025) & (Million Pill)
Figure 20. Erectile Dysfunction Consumed in Retail Pharmacies
Figure 21. Global Erectile Dysfunction Market: Retail Pharmacies (2020-2025) & (Million Pill)
Figure 22. Erectile Dysfunction Consumed in E-Commerce (B2B)
Figure 23. Global Erectile Dysfunction Market: E-Commerce (B2B) (2020-2025) & (Million Pill)
Figure 24. Erectile Dysfunction Consumed in E-Commerce (B2C)
Figure 25. Global Erectile Dysfunction Market: E-Commerce (B2C) (2020-2025) & (Million Pill)
Figure 26. Global Erectile Dysfunction Sale Market Share by Application (2024)
Figure 27. Global Erectile Dysfunction Revenue Market Share by Application in 2025
Figure 28. Erectile Dysfunction Sales by Company in 2025 (Million Pill)
Figure 29. Global Erectile Dysfunction Sales Market Share by Company in 2025
Figure 30. Erectile Dysfunction Revenue by Company in 2025 ($ millions)
Figure 31. Global Erectile Dysfunction Revenue Market Share by Company in 2025
Figure 32. Global Erectile Dysfunction Sales Market Share by Geographic Region (2020-2025)
Figure 33. Global Erectile Dysfunction Revenue Market Share by Geographic Region in 2025
Figure 34. Americas Erectile Dysfunction Sales 2020-2025 (Million Pill)
Figure 35. Americas Erectile Dysfunction Revenue 2020-2025 ($ millions)
Figure 36. APAC Erectile Dysfunction Sales 2020-2025 (Million Pill)
Figure 37. APAC Erectile Dysfunction Revenue 2020-2025 ($ millions)
Figure 38. Europe Erectile Dysfunction Sales 2020-2025 (Million Pill)
Figure 39. Europe Erectile Dysfunction Revenue 2020-2025 ($ millions)
Figure 40. Middle East & Africa Erectile Dysfunction Sales 2020-2025 (Million Pill)
Figure 41. Middle East & Africa Erectile Dysfunction Revenue 2020-2025 ($ millions)
Figure 42. Americas Erectile Dysfunction Sales Market Share by Country in 2025
Figure 43. Americas Erectile Dysfunction Revenue Market Share by Country (2020-2025)
Figure 44. Americas Erectile Dysfunction Sales Market Share byType (2020-2025)
Figure 45. Americas Erectile Dysfunction Sales Market Share by Application (2020-2025)
Figure 46. United States Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 47. Canada Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 48. Mexico Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 49. Brazil Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 50. APAC Erectile Dysfunction Sales Market Share by Region in 2025
Figure 51. APAC Erectile Dysfunction Revenue Market Share by Region (2020-2025)
Figure 52. APAC Erectile Dysfunction Sales Market Share byType (2020-2025)
Figure 53. APAC Erectile Dysfunction Sales Market Share by Application (2020-2025)
Figure 54. China Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 55. Japan Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 56. South Korea Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 57. Southeast Asia Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 58. India Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 59. Australia Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 60. ChinaTaiwan Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 61. Europe Erectile Dysfunction Sales Market Share by Country in 2025
Figure 62. Europe Erectile Dysfunction Revenue Market Share by Country (2020-2025)
Figure 63. Europe Erectile Dysfunction Sales Market Share byType (2020-2025)
Figure 64. Europe Erectile Dysfunction Sales Market Share by Application (2020-2025)
Figure 65. Germany Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 66.France Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 67. UK Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 68. Italy Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 69. Russia Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 70. Middle East & Africa Erectile Dysfunction Sales Market Share by Country (2020-2025)
Figure 71. Middle East & Africa Erectile Dysfunction Sales Market Share byType (2020-2025)
Figure 72. Middle East & Africa Erectile Dysfunction Sales Market Share by Application (2020-2025)
Figure 73. Egypt Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 74. South Africa Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 75. Israel Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 76.Turkey Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 77. GCC Countries Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Erectile Dysfunction in 2025
Figure 79. Manufacturing Process Analysis of Erectile Dysfunction
Figure 80. Industry Chain Structure of Erectile Dysfunction
Figure 81. Channels of Distribution
Figure 82. Global Erectile Dysfunction Sales MarketForecast by Region (2026-2031)
Figure 83. Global Erectile Dysfunction Revenue Market ShareForecast by Region (2026-2031)
Figure 84. Global Erectile Dysfunction Sales Market ShareForecast byType (2026-2031)
Figure 85. Global Erectile Dysfunction Revenue Market ShareForecast byType (2026-2031)
Figure 86. Global Erectile Dysfunction Sales Market ShareForecast by Application (2026-2031)
Figure 87. Global Erectile Dysfunction Revenue Market ShareForecast by Application (2026-2031)
Figure 1. Picture of Erectile Dysfunction
Figure 2. Erectile Dysfunction Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Erectile Dysfunction Sales Growth Rate 2020-2031 (Million Pill)
Figure 7. Global Erectile Dysfunction Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Erectile Dysfunction Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Erectile Dysfunction Sales Market Share by Country/Region (2024)
Figure 10. Erectile Dysfunction Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Sildenafil
Figure 12. Product Picture ofTadalafil
Figure 13. Product Picture of Others
Figure 14. Global Erectile Dysfunction Sales Market Share byType in 2025
Figure 15. Global Erectile Dysfunction Revenue Market Share byType (2020-2025)
Figure 16. Erectile Dysfunction Consumed in Hospital Pharmacies
Figure 17. Global Erectile Dysfunction Market: Hospital Pharmacies (2020-2025) & (Million Pill)
Figure 18. Erectile Dysfunction Consumed in Private Clinics
Figure 19. Global Erectile Dysfunction Market: Private Clinics (2020-2025) & (Million Pill)
Figure 20. Erectile Dysfunction Consumed in Retail Pharmacies
Figure 21. Global Erectile Dysfunction Market: Retail Pharmacies (2020-2025) & (Million Pill)
Figure 22. Erectile Dysfunction Consumed in E-Commerce (B2B)
Figure 23. Global Erectile Dysfunction Market: E-Commerce (B2B) (2020-2025) & (Million Pill)
Figure 24. Erectile Dysfunction Consumed in E-Commerce (B2C)
Figure 25. Global Erectile Dysfunction Market: E-Commerce (B2C) (2020-2025) & (Million Pill)
Figure 26. Global Erectile Dysfunction Sale Market Share by Application (2024)
Figure 27. Global Erectile Dysfunction Revenue Market Share by Application in 2025
Figure 28. Erectile Dysfunction Sales by Company in 2025 (Million Pill)
Figure 29. Global Erectile Dysfunction Sales Market Share by Company in 2025
Figure 30. Erectile Dysfunction Revenue by Company in 2025 ($ millions)
Figure 31. Global Erectile Dysfunction Revenue Market Share by Company in 2025
Figure 32. Global Erectile Dysfunction Sales Market Share by Geographic Region (2020-2025)
Figure 33. Global Erectile Dysfunction Revenue Market Share by Geographic Region in 2025
Figure 34. Americas Erectile Dysfunction Sales 2020-2025 (Million Pill)
Figure 35. Americas Erectile Dysfunction Revenue 2020-2025 ($ millions)
Figure 36. APAC Erectile Dysfunction Sales 2020-2025 (Million Pill)
Figure 37. APAC Erectile Dysfunction Revenue 2020-2025 ($ millions)
Figure 38. Europe Erectile Dysfunction Sales 2020-2025 (Million Pill)
Figure 39. Europe Erectile Dysfunction Revenue 2020-2025 ($ millions)
Figure 40. Middle East & Africa Erectile Dysfunction Sales 2020-2025 (Million Pill)
Figure 41. Middle East & Africa Erectile Dysfunction Revenue 2020-2025 ($ millions)
Figure 42. Americas Erectile Dysfunction Sales Market Share by Country in 2025
Figure 43. Americas Erectile Dysfunction Revenue Market Share by Country (2020-2025)
Figure 44. Americas Erectile Dysfunction Sales Market Share byType (2020-2025)
Figure 45. Americas Erectile Dysfunction Sales Market Share by Application (2020-2025)
Figure 46. United States Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 47. Canada Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 48. Mexico Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 49. Brazil Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 50. APAC Erectile Dysfunction Sales Market Share by Region in 2025
Figure 51. APAC Erectile Dysfunction Revenue Market Share by Region (2020-2025)
Figure 52. APAC Erectile Dysfunction Sales Market Share byType (2020-2025)
Figure 53. APAC Erectile Dysfunction Sales Market Share by Application (2020-2025)
Figure 54. China Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 55. Japan Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 56. South Korea Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 57. Southeast Asia Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 58. India Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 59. Australia Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 60. ChinaTaiwan Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 61. Europe Erectile Dysfunction Sales Market Share by Country in 2025
Figure 62. Europe Erectile Dysfunction Revenue Market Share by Country (2020-2025)
Figure 63. Europe Erectile Dysfunction Sales Market Share byType (2020-2025)
Figure 64. Europe Erectile Dysfunction Sales Market Share by Application (2020-2025)
Figure 65. Germany Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 66.France Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 67. UK Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 68. Italy Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 69. Russia Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 70. Middle East & Africa Erectile Dysfunction Sales Market Share by Country (2020-2025)
Figure 71. Middle East & Africa Erectile Dysfunction Sales Market Share byType (2020-2025)
Figure 72. Middle East & Africa Erectile Dysfunction Sales Market Share by Application (2020-2025)
Figure 73. Egypt Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 74. South Africa Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 75. Israel Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 76.Turkey Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 77. GCC Countries Erectile Dysfunction Revenue Growth 2020-2025 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Erectile Dysfunction in 2025
Figure 79. Manufacturing Process Analysis of Erectile Dysfunction
Figure 80. Industry Chain Structure of Erectile Dysfunction
Figure 81. Channels of Distribution
Figure 82. Global Erectile Dysfunction Sales MarketForecast by Region (2026-2031)
Figure 83. Global Erectile Dysfunction Revenue Market ShareForecast by Region (2026-2031)
Figure 84. Global Erectile Dysfunction Sales Market ShareForecast byType (2026-2031)
Figure 85. Global Erectile Dysfunction Revenue Market ShareForecast byType (2026-2031)
Figure 86. Global Erectile Dysfunction Sales Market ShareForecast by Application (2026-2031)
Figure 87. Global Erectile Dysfunction Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Dura Substitution Prosthesis Market Growth 2024-2030
US$ 3,660.00
February 2024
116 pages
Global In-Silico Drug Discovery Market Growth (Status and Outlook) 2026-2032
US$ 3,660.00
July 2026
139 pages
Global Glaucoma Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
September 2024
150 pages
Global Ear Tube Devices Market Growth 2025-2031
US$ 3,660.00
January 2025
97 pages
